Echo Therapeutics, Inc. (ECTE) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Price: $0.00 --0%
Financial Fact:
Total operating expenses: 1.81M
Today's EPS Names:
OFLX, AFIB, NMRD, More
Financial Fact:
Total operating expenses: 1.81M
Today's EPS Names:
OFLX, AFIB, NMRD, More
Join SI Premium – FREE
Echo Therapeutics, Inc. (NASDAQ: ECTE) reported Q3 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
